HBL - Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It operates in the fields of oncology, regenerative medicine, and inflammatory disease. The company develops biological drugs; and plasma RNA biomarkers for colorectal cancer. It offers ProtAb, an immunotherapeutic monoclonal antibody for the treatment of autoimmune inflammatory diseases. HBL - Hadasit Bio-Holdings Ltd was incorporated in 2005 and is based in Jerusalem, Israel.
Frequently asked questions
What sector does Hadasit Bio (HDST) operate in?
Hadasit Bio belongs to the Healthcare sector and operates in the Biotechnology & Medical Research industry.
What is Hadasit Bio (HDST) current stock price?
As of the latest data, Hadasit Bio stock price is ₪0.65, with a previous close of ₪0.65.
What is Hadasit Bio (HDST) current market capitalization?
Hadasit Bio market cap is approximately 7.19 million.
What is Hadasit Bio (HDST) Earnings Per Share (EPS)?
The trailing EPS is -₪2.81.
Does Hadasit Bio (HDST) pay dividends?
No. Hadasit Bio does not pay a dividend.
What is Hadasit Bio (HDST) beta (volatility) score?
Hadasit Bio has a beta of 0.585, indicating lower volatility than the overall market.